Search
Research
Finding the cellular explanation for recurrent asthma exacerbationsThis study is designed to identify the specific unique immune cell response that occurs in these children with recurrent disease.
Research
Studies on the immunological mechanisms underlying progression versus resolution of asthma between adolescence and adulthoodThis project seeks new information on asthma disease mechanisms, to help propel development of new and better anti-asthma drugs.
Research
Epigenetic changes underpinning allergen sensitization: a twin-based studyWe are studying immune cells from identical twins of which one suffers and one does not suffer from allergic disease to identify specific mechanisms that may pl
News & Events
ORIGINS reaches key milestoneORIGINS, a collaboration between The Kids and the Joondalup Health Campus, has achieved a major milestone – recruiting its 1000th family.
Research
A Phase III, randomized, controlled, observer-blind study to demonstrate effectiveness, immunogenicity and safety of GSK's meningococcal Group B and combined ABCWY vaccines when administered to healthy adolescents and young adults (Quintet)Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical
Research
A randomized, controlled, observer-blind, phase 1/2a study to evaluate the safety, reactogenicity, and immunogenicity of Ad26.RSV.preF in RSV-seronegative toddlers 12 to 24 months of ageJennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical
Research
Acute viral bronchiolitis in infants and young childrenAnya Deborah Pat Jones Strickland Holt BSc MSc PhD PhD PhD, DSc, FRCPath, FRCPI, FAA Honorary Research Associate Program Head, Immunobiology and
Research
Alert Program®Emma Glenn Martyn Adams Pearson Symons BExSc, MPH BA (Education) PhD Candidate B.A. (Hons) PhD. Acting Research Officer - Playce & PhD student
Research
Australian Strep A Vaccine Initiative (ASAVI)The Australian Strep A Vaccine Initiative (ASAVI) is an Australian-led global initiative with the goal of reducing the disease burden caused by Group A Streptococcus (Strep A) infection through effective vaccination.
Research
BANK CF: The Respiratory Centre BIOBANKInvestigators: Stephen Stick, Nat Eiffler, Nadzirah Bashir, Jaqueline Macpherson About BANK CF: Central to the research objectives of AREST CF is the